$BBWI
Bath & Body Works, Inc.

2024 Q2 Form 10-Q Financial Statement

#000070198524000018 Filed on June 04, 2024

View on sec.gov

Income Statement

Concept 2024 Q2
Revenue $1.384B
YoY Change -0.86%
Cost Of Revenue $778.0M
YoY Change -2.75%
Gross Profit $606.0M
YoY Change 1.68%
Gross Profit Margin 43.79%
Selling, General & Admin $419.0M
YoY Change 0.96%
% of Gross Profit 69.14%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $71.00M
YoY Change 12.7%
% of Gross Profit 11.72%
Operating Expenses $419.0M
YoY Change 0.96%
Operating Profit $187.0M
YoY Change 3.31%
Interest Expense $82.00M
YoY Change -192.13%
% of Operating Profit 43.85%
Other Income/Expense, Net $13.00M
YoY Change -35.0%
Pretax Income $118.0M
YoY Change 5.36%
Income Tax $31.00M
% Of Pretax Income 26.27%
Net Earnings $87.00M
YoY Change 7.41%
Net Earnings / Revenue 6.29%
Basic Earnings Per Share $0.39
Diluted Earnings Per Share $0.38
COMMON SHARES
Basic Shares Outstanding 225.0M shares
Diluted Shares Outstanding 226.0M shares

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $855.0M
YoY Change -18.26%
Cash & Equivalents $855.0M
Short-Term Investments
Other Short-Term Assets $127.0M
YoY Change 7.63%
Inventory $814.0M
Prepaid Expenses
Receivables $121.0M
Other Receivables $0.00
Total Short-Term Assets $1.917B
YoY Change -7.84%
LONG-TERM ASSETS
Property, Plant & Equipment $1.183B
YoY Change -48.45%
Goodwill $628.0M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $121.0M
YoY Change -3.97%
Other Assets $138.0M
YoY Change -29.23%
Total Long-Term Assets $3.304B
YoY Change 0.64%
TOTAL ASSETS
Total Short-Term Assets $1.917B
Total Long-Term Assets $3.304B
Total Assets $5.221B
YoY Change -2.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $403.0M
YoY Change -5.4%
Accrued Expenses $489.0M
YoY Change -34.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.221B
YoY Change -4.39%
LONG-TERM LIABILITIES
Long-Term Debt $4.282B
YoY Change -10.44%
Other Long-Term Liabilities $257.0M
YoY Change -80.34%
Total Long-Term Liabilities $4.539B
YoY Change -25.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.221B
Total Long-Term Liabilities $4.539B
Total Liabilities $5.760B
YoY Change -23.54%
SHAREHOLDERS EQUITY
Retained Earnings -$1.889B
YoY Change -20.16%
Common Stock $960.0M
YoY Change 2.13%
Preferred Stock
YoY Change
Treasury Stock (at cost) $822.0M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$1.677B
YoY Change
Total Liabilities & Shareholders Equity $5.221B
YoY Change -2.65%

Cashflow Statement

Concept 2024 Q2
OPERATING ACTIVITIES
Net Income $87.00M
YoY Change 7.41%
Depreciation, Depletion And Amortization $71.00M
YoY Change 12.7%
Cash From Operating Activities $76.00M
YoY Change 72.73%
INVESTING ACTIVITIES
Capital Expenditures $46.00M
YoY Change -50.54%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$46.00M
YoY Change -51.06%
FINANCING ACTIVITIES
Cash Dividend Paid $45.00M
YoY Change -2.17%
Common Stock Issuance & Retirement, Net $96.00M
YoY Change
Debt Paid & Issued, Net $110.0M
YoY Change 48.65%
Cash From Financing Activities -$259.0M
YoY Change 91.85%
NET CHANGE
Cash From Operating Activities $76.00M
Cash From Investing Activities -$46.00M
Cash From Financing Activities -$259.0M
Net Change In Cash -$229.0M
YoY Change 23.78%
FREE CASH FLOW
Cash From Operating Activities $76.00M
Capital Expenditures $46.00M
Free Cash Flow $30.00M
YoY Change -161.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-05-04
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus,
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43230
CY2024Q2 dei City Area Code
CityAreaCode
(614)
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
415-7000
CY2024Q2 dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
Not Applicable
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.50 Par Value
CY2024Q2 dei Trading Symbol
TradingSymbol
BBWI
CY2024Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
223231399 shares
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 dei Entity File Number
EntityFileNumber
1-8344
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
BATH & BODY WORKS, INC.
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-1029810
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
Three Limited Parkway
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
778000000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
800000000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
606000000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
596000000 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
419000000 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
415000000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
187000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
181000000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
82000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
89000000 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
118000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
112000000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
87000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81000000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
87000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
86000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
80000000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
855000000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1084000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1046000000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
121000000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
224000000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
145000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
814000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
710000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
771000000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
127000000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
97000000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
118000000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1917000000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2115000000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2080000000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1183000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1220000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1223000000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1047000000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1056000000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1072000000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
628000000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
628000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
628000000 usd
CY2024Q2 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
165000000 usd
CY2024Q1 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
165000000 usd
CY2023Q2 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
165000000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
143000000 usd
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
144000000 usd
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37000000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
138000000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
135000000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
158000000 usd
CY2024Q2 us-gaap Assets
Assets
5221000000 usd
CY2024Q1 us-gaap Assets
Assets
5463000000 usd
CY2023Q2 us-gaap Assets
Assets
5363000000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
403000000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
380000000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
426000000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
489000000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
608000000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
585000000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
186000000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
181000000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
165000000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
143000000 usd
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
120000000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
101000000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1221000000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1289000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1277000000 usd
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
147000000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
147000000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
168000000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4282000000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4388000000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4781000000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
990000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1004000000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1032000000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
257000000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
261000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
275000000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
238000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
240000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
244000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
223000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
225000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
229000000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
119000000 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
120000000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
122000000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
841000000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
838000000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
818000000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
74000000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
75000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
77000000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1889000000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1838000000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2366000000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15000000 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15000000 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15000000 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
822000000 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
822000000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
822000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1677000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1627000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2171000000 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
1000000 usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
1000000 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
1000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1676000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1626000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2170000000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5221000000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5463000000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5363000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1626000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
87000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
86000000 usd
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2024Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
45000000 usd
CY2024Q2 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8000000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1676000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2205000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
80000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2023Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
46000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2170000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
87000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
81000000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
71000000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
63000000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12000000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7000000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7000000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-103000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-81000000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
105000000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63000000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-101000000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-113000000 usd
CY2024Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
25000000 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
23000000 usd
CY2024Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
17000000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
28000000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44000000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
93000000 usd
CY2024Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1000000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94000000 usd
CY2024Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
110000000 usd
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
74000000 usd
CY2024Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
96000000 usd
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
45000000 usd
CY2023Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
46000000 usd
CY2024Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2023Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8000000 usd
CY2024Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7000000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-259000000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-135000000 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-229000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-186000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1084000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1232000000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
855000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1046000000 usd
CY2024Q2 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div>The Company’s fiscal year ends on the Saturday nearest to January 31. As used herein, “first quarter of 2024” and “first quarter of 2023” refer to the thirteen-week periods ended May 4, 2024 and April 29, 2023, respectively.
CY2024Q2 bbwi Number Of Selling Seasons
NumberOfSellingSeasons
2 season
CY2024Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains cash and cash equivalents and derivative contracts with various major financial institutions. The Company monitors the relative credit standing of financial institutions with whom it transacts and limits the amount of credit exposure with any one entity. The Company’s investment portfolio is primarily composed of U.S. government obligations, U.S. Treasury and AAA-rated money market funds, commercial paper and bank deposits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also periodically reviews the relative credit standing of franchise, license and wholesale partners and other entities to which it grants credit terms in the normal course of business. The Company determines the required allowance for expected credit losses using information such as customer credit history and financial condition. Amounts are recorded to the allowance when it is determined that expected credit losses may occur.</span></div>
CY2024Q2 bbwi Easton Investments Including Carrying Value Of Related Equity Method Investments
EastonInvestmentsIncludingCarryingValueOfRelatedEquityMethodInvestments
121000000 usd
CY2024Q1 bbwi Easton Investments Including Carrying Value Of Related Equity Method Investments
EastonInvestmentsIncludingCarryingValueOfRelatedEquityMethodInvestments
120000000 usd
CY2023Q2 bbwi Easton Investments Including Carrying Value Of Related Equity Method Investments
EastonInvestmentsIncludingCarryingValueOfRelatedEquityMethodInvestments
126000000 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the related disclosure of contingent assets and liabilities at the date of the financial statements. Actual results may differ from those estimates, and the Company revises its estimates and assumptions as new information becomes available.</span></div>
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
74000000 usd
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
84000000 usd
CY2023Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
79000000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
178000000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
198000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
171000000 usd
CY2024Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
71000000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1384000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1396000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
240000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
244000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
15000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Treasury Stock
WeightedAverageNumberOfSharesTreasuryStock
15000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
225000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
229000000 shares
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
226000000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
230000000 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000 shares
CY2024Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
2171000 shares
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2024Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
45000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2023Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
46000000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
673000000 usd
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
558000000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
611000000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
141000000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
152000000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
160000000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
814000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
710000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
771000000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3129000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3123000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2993000000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1946000000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1903000000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1770000000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1183000000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1220000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1223000000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
71000000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
63000000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.277
CY2024Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000000 usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
7000000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
4282000000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
4388000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
4781000000 usd
CY2024Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
109000000 usd
CY2024Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
110000000 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000 usd
CY2023Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
84000000 usd
CY2023Q2 bbwi Aggregate Purchase Price Of Debt Extinguishment
AggregatePurchasePriceOfDebtExtinguishment
76000000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7000000 usd
CY2023Q2 bbwi Repayments Of Debt Reflected In Accounts Payable
RepaymentsOfDebtReflectedInAccountsPayable
2000000 usd
CY2024Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
109000000 usd
CY2023Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
84000000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
bbwi-20240504_cal.xml Edgar Link unprocessable
0000701985-24-000018-index-headers.html Edgar Link pending
0000701985-24-000018-index.html Edgar Link pending
0000701985-24-000018.txt Edgar Link pending
0000701985-24-000018-xbrl.zip Edgar Link pending
bbwi-20240504.htm Edgar Link pending
bbwi-20240504.xsd Edgar Link pending
bbwi-202454_ex15.htm Edgar Link pending
bbwi-202454_ex22.htm Edgar Link pending
bbwi-202454_ex311.htm Edgar Link pending
bbwi-202454_ex312.htm Edgar Link pending
bbwi-202454_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
bbwi-20240504_def.xml Edgar Link unprocessable
bbwi-20240504_lab.xml Edgar Link unprocessable
bbwi-20240504_pre.xml Edgar Link unprocessable
bbwi-20240504_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable